ID

23501

Description

A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00559754

Link

https://clinicaltrials.gov/show/NCT00559754

Keywords

  1. 7/8/17 7/8/17 -
Uploaded on

July 8, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00559754

Eligibility Breast Cancer NCT00559754

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients, >=18 years of age;
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
primary her2-negative operable breast cancer;
Description

Breast Carcinoma Primary HER2 negative Operable

Data type

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205225
UMLS CUI [1,3]
C4087376
UMLS CUI [1,4]
C0205188
tumor >2cm in size;
Description

Tumor size

Data type

boolean

Alias
UMLS CUI [1]
C0475440
ecog performance status 0-1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment for breast cancer;
Description

Prior Therapy Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0678222
metastatic disease;
Description

Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0027627
current or recent (within 10 days of first dose of avastin) use of aspirin (>325mg/day) or full-dose anticoagulants for therapeutic purposes;
Description

Aspirin U/day | Avastin | Anticoagulants Dose Full

Data type

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
UMLS CUI [2]
C1135130
UMLS CUI [3,1]
C0003280
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0443225
clinically significant cardiovascular disease.
Description

Cardiovascular Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0007222

Similar models

Eligibility Breast Cancer NCT00559754

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
female patients, >=18 years of age;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Breast Carcinoma Primary HER2 negative Operable
Item
primary her2-negative operable breast cancer;
boolean
C0678222 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C4087376 (UMLS CUI [1,3])
C0205188 (UMLS CUI [1,4])
Tumor size
Item
tumor >2cm in size;
boolean
C0475440 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Therapy Breast Carcinoma
Item
previous treatment for breast cancer;
boolean
C1514463 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
Neoplasm Metastasis
Item
metastatic disease;
boolean
C0027627 (UMLS CUI [1])
Aspirin U/day | Avastin | Anticoagulants Dose Full
Item
current or recent (within 10 days of first dose of avastin) use of aspirin (>325mg/day) or full-dose anticoagulants for therapeutic purposes;
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C1135130 (UMLS CUI [2])
C0003280 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0443225 (UMLS CUI [3,3])
Cardiovascular Diseases
Item
clinically significant cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial